Clinical Trial

Fecal Amino Acids，Gut Taste Receptors and Irritable Bowel Syndromes

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 8, 2024 (before its estimated August 2024 completion). Its status may not reflect the trial's current state.
Summary
Clinical data, fresh feces and intestinal mucosal tissues of patients with diarrheal IBS were collected. High performance liquid chromatography, immunohistochemistry and immunofluorescence were used to study the amino acid levels in feces of patients with IBS, the expression of taste receptors in intestinal mucosa, and the correlation between symptoms of abdominal pain and diarrhea and the expression of taste receptors, so as to obtain the conclusion that "intestinal amino acid perception abnormalities exist in patients with IBS. And correlated with clinical symptoms."
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06489444
Lead Sponsor Second Affiliated Hospital of Xi'an Jiaotong University
Conditions Irritable Bowel Syndrome
Enrollment 100 participants
Start Date 2023-03-16
Primary Completion 2024-08 (estimated)
Study Completion 2024-08 (estimated)
Updated on ClinicalTrials.gov 2024-07-08